Which triptan is cited as having pediatric approval with weight-based dosing?

Which triptan is cited as having pediatric approval with weight-based dosing?

• A. Sumatriptan
• B. Zolmitriptan
• C. Rizatriptan
• D. Almotriptan

Answer: (C)

In children, dosing often needs to be adjusted by body weight to achieve the right drug exposure. Rizatriptan stands out because its pediatric labeling explicitly uses weight-based dosing for migraine treatment in young patients. For kids aged 6 to 17, the dose is 5 mg if the child weighs under 40 kg and 10 mg if they weigh 40 kg or more, given once per attack. This weight-based approach helps tailor therapy to the child’s size and pharmacokinetics, improving efficacy while maintaining safety. Other triptans may be approved for pediatric use, but their labeling typically relies on fixed or age-based dosing rather than weight-based dosing, so rizatriptan best fits the criterion.

In children, dosing often needs to be adjusted by body weight to achieve the right drug exposure. Rizatriptan stands out because its pediatric labeling explicitly uses weight-based dosing for migraine treatment in young patients. For kids aged 6 to 17, the dose is 5 mg if the child weighs under 40 kg and 10 mg if they weigh 40 kg or more, given once per attack. This weight-based approach helps tailor therapy to the child’s size and pharmacokinetics, improving efficacy while maintaining safety. Other triptans may be approved for pediatric use, but their labeling typically relies on fixed or age-based dosing rather than weight-based dosing, so rizatriptan best fits the criterion.